Lycium barbarum (Goji Berry) extracts and its taurine component inhibit PPAR-γ-dependent gene transcription in human retinal pigment epithelial cells: Possible implications for diabetic retinopathy treatment

Biochemical Pharmacology

Volumn 82, Issue 9, 2011, Pages 1209-1218

  Song, M K ^a   Salam, N K ^a   Roufogalis, Basil D ^a   Huang, T H W ^a  

^a University of Sydney   (Australia)

Author keywords

Diabetic retinopathy; Human retinal pigment epithelial cell; Lycium barbarum; Peroxisome proliferator activated receptor ; Taurine

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; CYCLOOXYGENASE 2; FIBRONECTIN; GELATINASE B; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; LUCIFERASE; LYCIUM BARBARUM EXTRACT; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TAURINE;

ARTICLE; DIABETIC RETINOPATHY; DISEASE COURSE; DOSE RESPONSE; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVITY; EPITHELIUM CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; MOLECULAR DOCKING; MOLECULAR INTERACTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; RETINA CELL;

BINDING SITES; CELL LINE; DIABETIC RETINOPATHY; DOWN-REGULATION; EPITHELIAL CELLS; GLUCOSE; HUMANS; LYCIUM; MOLECULAR STRUCTURE; PLANT EXTRACTS; PPAR GAMMA; PROTEIN BINDING; RETINAL PIGMENT EPITHELIUM; RNA, MESSENGER; TAURINE; TRANSCRIPTION, GENETIC;

EID: 80053941906     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.07.089     Document Type: Article

References (91)

1. F. Malchiodi-Albedi, A. Matteucci, A. Bernardo, L. Minghetti, and PPAR-gamma Microglial cells, and ocular inflammation: new venues for potential therapeutic approaches PPAR Res 2008 2008 295784
2. P.A. Sarafidis, and G.L. Bakris Protection of the kidney by thiazolidinediones: an assessment from bench to bedside Kidney Int 70 2006 1223 1233 (Pubitemid 44435173)
3. B.P. Kota, T.H. Huang, and B.D. Roufogalis An overview on biological mechanisms of PPARs Pharmacol Res 51 2005 85 94 (Pubitemid 40040538)
4. D.S. Straus, and C.K. Glass Cyclopentenone prostaglandins: new insights on biological activities and cellular targets Med Res Rev 21 2001 185 210 (Pubitemid 32303994)
5. A.V. Ershov, and N.G. Bazan Photoreceptor phagocytosis selectively activates PPAR gamma expression in retinal pigment epithelial cells J Neurosci Res 60 2000 328 337 (Pubitemid 30253596)
6. J.M. Lehmann, L.B. Moore, T.A. Smith-Oliver, W.O. Wilkison, T.M. Willson, and S.A. Kliewer An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) J Biol Chem 270 1995 12953 12956
7. M.A. Sarayba, L. Li, T. Tungsiripat, N.H. Liu, P.M. Sweet, and A.J. Patel Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand Exp Eye Res 80 2005 435 442 (Pubitemid 40249898)
8. A.A. Herzlich, J. Tuo, and C.C. Chan Peroxisome proliferator-activated receptor and age-related macular degeneration PPAR Res 2008 2008 389507
9. T. Murata, S. He, M. Hangai, T. Ishibashi, X.P. Xi, and S. Kim Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization Invest Ophthalmol Vis Sci 41 2000 2309 2317 (Pubitemid 30451008)
10. A. Tawfik, T. Sanders, K. Kahook, S. Akeel, A. Elmarakby, and M. Al-Shabrawey Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase Invest Ophthalmol Vis Sci 50 2009 878 884
11. K. Muranaka, Y. Yanagi, Y. Tamaki, T. Usui, N. Kubota, and A. Iriyama Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model Invest Ophthalmol Vis Sci 47 2006 4547 4552 (Pubitemid 46579384)
12. X. Xin, S. Yang, J. Kowalski, and M.E. Gerritsen Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo J Biol Chem 274 1999 9116 9121 (Pubitemid 29164719)
13. L.Q. Shen, A. Child, G.M. Weber, J. Folkman, and L.P. Aiello Rosiglitazone and delayed onset of proliferative diabetic retinopathy Arch Ophthalmol 126 2008 793 799 (Pubitemid 351831328)
14. D.S. Fong, L. Aiello, T.W. Gardner, G.L. King, G. Blankenship, and J.D. Cavallerano Retinopathy in diabetes Diabetes Care 27 Suppl. 1 2004 S84 S87
15. R. Williams, M. Airey, H. Baxter, J. Forrester, T. Kennedy-Martin, and A. Girach Epidemiology of diabetic retinopathy and macular oedema: a systematic review Eye 18 2004 963 983 (Pubitemid 39430033)
16. T.A. Ciulla, A.G. Amador, and B. Zinman Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies Diabetes Care 26 2003 2653 2664 (Pubitemid 37055447)
17. M. Mizutani, T.S. Kern, and M. Lorenzi Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy J Clin Invest 97 1996 2883 2890 (Pubitemid 26197103)
18. H.P. Hammes, D. Strodter, A. Weiss, R.G. Bretzel, K. Federlin, and M. Brownlee Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model Diabetologia 38 1995 656 660
19. A. Decanini, P.R. Karunadharma, C.L. Nordgaard, X. Feng, T.W. Olsen, and D.A. Ferrington Human retinal pigment epithelium proteome changes in early diabetes Diabetologia 51 2008 1051 1061
20. L.J. Rizzolo Polarity and the development of the outer blood-retinal barrier Histol Histopathol 12 1997 1057 1067 (Pubitemid 27410463)
21. D. Bok The retinal pigment epithelium: a versatile partner in vision J Cell Sci Suppl 17 1993 189 195 (Pubitemid 24041298)
22. C.J. Kennedy, P.E. Rakoczy, and I.J. Constable Lipofuscin of the retinal pigment epithelium: a review Eye (Lond) 9 Pt 6 1995 763 771 (Pubitemid 26018204)
23. K. Kimoto, K. Nakatsuka, N. Matsuo, and H. Yoshioka p38 MAPK mediates the expression of type I collagen induced by TGF-beta 2 in human retinal pigment epithelial cells ARPE-19 Invest Ophthalmol Vis Sci 45 2004 2431 2437 (Pubitemid 38902619)
24. P.S. Chan, M. Kanwar, and R.A. Kowluru Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memory J Diabetes Complications 24 2008 55 63
25. H.A. Pershadsingh, D.M. Moore, and PPARgamma Agonists Potential as therapeutics for neovascular retinopathies PPAR Res 2008 2008 164273
26. Q. Luo, Y. Cai, J. Yan, M. Sun, and H. Corke Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum Life Sci 76 2004 137 149 (Pubitemid 39425220)
27. G. Cao, H.M. Alessio, and R.G. Cutler Oxygen-radical absorbance capacity assay for antioxidants Free Radic Biol Med 14 1993 303 311 (Pubitemid 23066371)
28. X. Peng, and G. Tian Structural characterization of the glycan part of glycoconjugate LbGp2 from Lycium barbarum L. Carbohydr Res 331 2001 95 99 (Pubitemid 32182316)
29. Y. Wang, H. Zhao, X. Sheng, P.E. Gambino, B. Costello, and K. Bojanowski Protective effect of Fructus Lycii polysaccharides against time and hyperthermia-induced damage in cultured seminiferous epithelium J Ethnopharmacol 82 2002 169 175 (Pubitemid 35292043)
30. C.Y. Cheng, W.Y. Chung, Y.T. Szeto, and I.F. Benzie Fasting plasma zeaxanthin response to Fructus barbarum L. (wolfberry; Kei Tze) in a food-based human supplementation trial Br J Nutr 93 2005 123 130
31. K. Chiu, H.C. Chan, S.C. Yeung, W.H. Yuen, S.Y. Zee, and R.C. Chang Modulation of microglia by Wolfberry on the survival of retinal ganglion cells in a rat ocular hypertension model J Ocul Biol Dis Inform 2 2009 47 56
32. H.C. Chan, R.C. Chang, A. Koon-Ching Ip, K. Chiu, W.H. Yuen, and S.Y. Zee Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma Exp Neurol 203 2007 269 273 (Pubitemid 44821159)
33. H. Xie, and S. Zhang Determination of taurine in Lycium barbarum L. by high performance liquid chromatography with OPA-urea pre-column derivatization Se Pu 15 1997 54 56
34. Y. Cao, X. Zhang, Q. Chu, Y. Fang, and J. Ye Determination of taurine in Lycium Barbarum L. and other foods by capillary electrophoresis with electrochemical detection Electroanalysis 15 2003 898 902
35. G. Donadio, and P. Fromageot Influence exerted by taurine on the utilization of glucose by the rat Bull Soc Chim Biol (Paris) 46 1964 293 302
36. W.G. Lampson, J.H. Kramer, and S.W. Schaffer Potentiation of the actions of insulin by taurine Can J Physiol Pharmacol 61 1983 457 463 (Pubitemid 13033242)
37. E.C. Kulakowski, and J. Maturo Does taurine bind to the insulin binding site of the insulin receptor? Prog Clin Biol Res 351 1990 95 102
38. J. Maturo, and E.C. Kulakowski Taurine binding to the purified insulin receptor Biochem Pharmacol 37 1988 3755 3760
39. M.F. McCarty Exploiting complementary therapeutic strategies for the treatment of type II diabetes and prevention of its complications Med Hypotheses 49 1997 143 152 (Pubitemid 27316532)
40. X. Yu, Z. Xu, M. Mi, H. Xu, J. Zhu, and N. Wei Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats Neurochem Res 33 2008 500 507 (Pubitemid 351230452)
41. M. Ganzera, J. Zhao, and I.A. Khan Analysis of terpenelactones in Ginkgo biloba by high performance liquid chromatography and evaporative light scattering detection Chem Pharm Bull (Tokyo) 49 2001 1170 1173 (Pubitemid 32847526)
42. A.D. Kaur, V. Ravichandran, P.K. Jain, and R.K. Agrawal High-performance thin layer chromatography method for estimation of conessine in herbal extract and pharmaceutical dosage formulations J Pharm Biomed Anal 46 2008 391 394
43. M. Aranda, and G. Morlock Simultaneous determination of riboflavin, pyridoxine, nicotinamide, caffeine and taurine in energy drinks by planar chromatography-multiple detection with confirmation by electrospray ionization mass spectrometry J Chromatogr A 1131 2006 253 260 (Pubitemid 44485658)
44. K.C. Dunn, A.E. Aotaki-Keen, F.R. Putkey, and L.M. Hjelmeland ARPE-19, a human retinal pigment epithelial cell line with differentiated properties Exp Eye Res 62 1996 155 169 (Pubitemid 26140102)
45. T. Yokoyama, K. Yamane, A. Minamoto, H. Tsukamoto, H. Yamashita, and S. Izumi High glucose concentration induces elevated expression of anti-oxidant and proteolytic enzymes in cultured human retinal pigment epithelial cells Exp Eye Res 83 2006 602 609 (Pubitemid 44183804)
46. K.S. Bramlett, K.A. Houck, K.M. Borchert, M.S. Dowless, P. Kulanthaivel, and Y. Zhang A natural product ligand of the oxysterol receptor, liver X receptor J Pharmacol Exp Ther 307 2003 291 296 (Pubitemid 37151920)
47. M.I. Patel, R. Tuckerman, and Q. Dong A pitfall of the 3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethonyphenol)-2-(4-sulfophenyl)-2 H-tetrazolium (MTS) assay due to evaporation in wells on the edge of a 96 well plate Biotechnol Lett 27 2005 805 808 (Pubitemid 41186006)
48. K.S. Frederiksen, E.M. Wulff, P. Sauerberg, J.P. Mogensen, L. Jeppesen, and J. Fleckner Prediction of PPAR-alpha ligand-mediated physiological changes using gene expression profiles J Lipid Res 45 2004 592 601 (Pubitemid 38338007)
49. A. Abe, Y. Kiriyama, M. Hirano, T. Miura, H. Kamiya, and H. Harashima Troglitazone suppresses cell growth of KU812 cells independently of PPAR gamma Eur J Pharmacol 436 2002 7 13 (Pubitemid 34142392)
50. G.F. Davies, P.J. McFie, R.L. Khandelwal, and W.J. Roesler Unique ability of troglitazone to up-regulate peroxisome proliferator-activated receptor-gamma expression in hepatocytes J Pharmacol Exp Ther 300 2002 72 77 (Pubitemid 34028510)
51. H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, and H. Weissig The protein data bank Nucleic Acids Res 28 2000 235 242 (Pubitemid 30047768)
52. Maestro LLC Maestro, version 9. 1 2010 Schrödinger, LLC New York, NY
53. Impact Impact, version 5. 6 2010 Schrödinger, LLC New York, NY
54. W. Sherman, T. Day, M.P. Jacobson, R.A. Friesner, and R. Farid Novel procedure for modeling ligand/receptor induced fit effects J Med Chem 49 2006 534 553 (Pubitemid 43157487)
55. Glide Glide, version 5.6 2010 Schrödinger, LLC New York, NY
56. Prime Prime, version 2.2 2010 Schrödinger, LLC New York, NY
57. R.T. Gampe Jr., V.G. Montana, M.H. Lambert, A.B. Miller, R.K. Bledsoe, and M.V. Milburn Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors Mol Cell 5 2000 545 555
58. P. Libby, and J. Plutzky Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists Am J Cardiol 99 2007 27B 40B
59. K.L. Bate, and G. Jerums 3: Preventing complications of diabetes Med J Aust 179 2003 498 503 (Pubitemid 37427791)
60. S.V. Edelman, and C.M. Morello Strategies for insulin therapy in type 2 diabetes South Med J 98 2005 363 371 (Pubitemid 40381716)
61. D.S. Fong, L. Aiello, T.W. Gardner, G.L. King, G. Blankenship, and J.D. Cavallerano Diabetic retinopathy Diabetes Care 26 2003 226 229 (Pubitemid 36934461)
62. C.A. Shah Diabetic retinopathy: a comprehensive review Indian J Med Sci 62 2008 500 519
63. Z.T. Bloomgarden Screening for and managing diabetic retinopathy: current approaches Am J Health Syst Pharm 64 2007 S8 S14
64. C. Garcia, J. Aranda, E. Arnold, S. Thebault, Y. Macotela, and F. Lopez-Casillas Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation J Clin Invest 118 2008 2291 2300 (Pubitemid 351872346)
65. A.M. Abu El-Asrar, H.S. Al-Mezaine, and M.S. Ola Pathophysiology and management of diabetic retinopathy Expert Rev Ophthalmol 4 2009 627 647
66. A.M. Joussen, T. Murata, A. Tsujikawa, B. Kirchhof, S.E. Bursell, and A.P. Adamis Leukocyte-mediated endothelial cell injury and death in the diabetic retina Am J Pathol 158 2001 147 152 (Pubitemid 32096479)
67. 12,14-prostaglandin J(2) PPAR Res 2008 2008 720163
68. S. Rahbar, R. Natarajan, K. Yerneni, S. Scott, N. Gonzales, and J.L. Nadler Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation Clin Chim Acta 301 2000 65 77
69. G. Sobal, E.J. Menzel, and H. Sinzinger Troglitazone inhibits long-term glycation and oxidation of low-density lipoprotein J Cardiovasc Pharmacol 46 2005 672 680 (Pubitemid 41527761)
70. 2 prevents reactive oxygen species generation and mitochondrial membrane depolarization induced by oxidative stress Biomed Chromatogr Pharmacol 4 2004 6
71. R.C. Chang, and K.F. So Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated diseases. What do we know so far? Cell Mol Neurobiol 28 2008 643 652 (Pubitemid 351905068)
72. R.M. Touyz, and E.L. Schiffrin Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications Vascul Pharmacol 45 2006 19 28 (Pubitemid 43963482)
73. M.S. Yu, S.K. Leung, S.W. Lai, C.M. Che, S.Y. Zee, and K.F. So Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against beta-amyloid peptide neurotoxicity Exp Gerontol 40 2005 716 727 (Pubitemid 41265822)
74. Y.S. Ho, M.S. Yu, X.F. Yang, K.F. So, W.H. Yuen, and R.C. Chang Neuroprotective effects of polysaccharides from Wolfberry, the fruits of Lycium barbarum, against homocysteine-induced toxicity in rat cortical neurons J Alzheimer's Dis 19 2009 813 827
75. M. Tomi, T. Terayama, T. Isobe, F. Egami, A. Morito, and M. Kurachi Function and regulation of taurine transport at the inner blood-retinal barrier Microvasc Res 73 2007 100 106 (Pubitemid 46241230)
76. K. Kawasaki Preretinopathic changes in the oscillatory potential in diabetic retina: interpretation and significance Nippon Ganka Gakkai Zasshi 102 1998 813 836 (Pubitemid 29016974)
77. H. Pasantes-Morales, J. Klethi, M. Ledig, and P. Mandel Free amino acids of chicken and rat retina Brain Res 41 1972 494 497
78. C. Vilchis, and R. Salceda Effect of diabetes on levels and uptake of putative amino acid neurotransmitters in rat retina and retinal pigment epithelium Neurochem Res 21 1996 1167 1171 (Pubitemid 26357266)
79. K.C. Hayes, R.E. Carey, and S.Y. Schmidt Retinal degeneration associated with taurine deficiency in the cat Science 188 1975 949 951
80. T. Takatani, K. Takahashi, Y. Uozumi, T. Matsuda, T. Ito, and S.W. Schaffer Taurine prevents the ischemia-induced apoptosis in cultured neonatal rat cardiomyocytes through Akt/caspase-9 pathway Biochem Biophys Res Commun 316 2004 484 489 (Pubitemid 38338617)
81. M. Rendell, and G.D. Lundberg Advances in diabetes for the millennium: an e-symposium MedGenMed 6 2004 15
82. A.H. Barnett, P.J. Grant, G.A. Hitman, H. Mather, M. Pawa, and L. Robertson Rosiglitazone in type 2 diabetes mellitus: an evaluation in British Indo-Asian patients Diabet Med 20 2003 387 393 (Pubitemid 36605624)
83. U. Khanderia, R. Pop-Busui, and K.A. Eagle Thiazolidinediones in type 2 diabetes: a cardiology perspective Ann Pharmacother 42 2008 1466 1474
84. B. Roehr FDA committee urges tight restrictions on rosiglitazone Br Med J 341 2010 c3862
85. A.F. Ceylan-Isik, R.M. Fliethman, L.E. Wold, and J. Ren Herbal and traditional Chinese medicine for the treatment of cardiovascular complications in diabetes mellitus Curr Diab Rev 4 2008 320 328
86. M.K. Song, B.D. Roufogalis, and T.H. Huang Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-gamma-related pharmacology Br J Pharmacol 2011 [Epub ahead of print]
87. T. Bouckenooghe, C. Remacle, and B. Reusens Is taurine a functional nutrient? Curr Opin Clin Nutr Metab Care 9 2006 728 733 (Pubitemid 44624621)
88. F. Franconi, M.A. Di Leo, F. Bennardini, and G. Ghirlanda Is taurine beneficial in reducing risk factors for diabetes mellitus? Neurochem Res 29 2004 143 150 (Pubitemid 38181708)
89. L. Chang, J. Zhao, J. Xu, W. Jiang, C.S. Tang, and Y.F. Qi Effects of taurine and homocysteine on calcium homeostasis and hydrogen peroxide and superoxide anions in rat myocardial mitochondria Clin Exp Pharmacol Physiol 31 2004 237 243 (Pubitemid 38507864)
90. G.Y. Oudit, M.G. Trivieri, N. Khaper, T. Husain, G.J. Wilson, and P. Liu Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model Circulation 109 2004 1877 1885 (Pubitemid 38509123)
91. C.S. Ahn Effect of taurine supplementation on plasma homocysteine levels of the middle-aged Korean women Adv Exp Med Biol 643 2009 415 422